0 评论
0 分享
666 浏览次数
0 评价
搜索
发现新朋友,建立新联系,结交新朋友
-
请登录以点赞、分享和评论!
-
New Application Scenarios for the AS01 Adjuvant: The ACI-24.060 Alzheimer’s Disease Vaccine ProjectThe treatment of Alzheimer’s Disease (AD) has entered the era of "Disease-Modifying Therapies" (DMTs). With the approval of anti-Aβ monoclonal antibodies (such as Lecanemab), the Amyloid Cascade Hypothesis has received clinical validation. However, the safety risks associated with ARIA (Amyloid-Related Imaging Abnormalities) in monoclonal antibody therapies, as well as their high...0 评论 0 分享 292 浏览次数 0 评价
-
The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza VaccinesInfluenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...0 评论 0 分享 6 浏览次数 0 评价
-
【Dual Exhibition Tour】GC Biotech's June Roadshow: Veterinary Adjuvant Innovation × Human Vaccine Breakthrough – Dual Tracks Driving the Future of ImmunityThis June, GC Biotech will participate in two major industry exhibitions in China, bringing together the latest innovations in veterinary drugs, vaccine adjuvants, and pharmaceutical technologies. These events provide an important platform for global collaboration, technological exchange, and industry advancement. We sincerely invite partners and industry professionals to visit us, explore new...0 评论 0 分享 833 浏览次数 0 评价